revefenacin (Compound)

Synonyms:Revefenacin, 864750-70-9, TD-4208, Yupelri, GSK-1160724, GSK1160724, UNII-G2AE2VE07O, G2AE2VE07O, 864750-70-9 (free base), [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate, 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate, 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate, TD-4208; GSK-1160724;[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate, Revefenacin [INN], Revefenacin [WHO-DD], Revefenacin (USAN/INN), Revefenacin [USAN:INN], Revefenacin;GSK1160724, SCHEMBL356480, CHEMBL3833319, GTPL10129, HMS3886K17, AMY16789, BCP15793, EX-A1722, s5258, TD4208, AKOS037649398, CCG-270187, CS-7743, DB11855, SB17262, BS-18189, HY-15851, Revefenacin; TD-4208; GSK-1160724, D10978, A903445, Q27278649, Revefenacin; TD 4208; TD4208; GSK-1160724; GSK1160724; GSK 1160724, 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate, Biphenyl-2-ylcarbamic acid, 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester, Carbamic acid, N-(1,1'-biphenyl)-2-yl-, 1-(2-((4-((4-(aminocarbonyl)-1-piperidinyl)methyl)benzoyl)methylamino)ethyl)-4-piperidinyl ester, TD-4208; TD 4208; TD4208; GSK-1160724; GSK1160724;1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl N-((1,1'-biphenyl)-2-yl)carbamate

Pubchem:PUBCHEM:11753673

Id:94095033-1f27-5727-a9cb-03cd8a6da466

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View revefenacin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for revefenacin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with revefenacin.

Results found

Linked to

	Label	Description
	revefenacin (2c107843-3c56-4ffc-9cee-491d347b8cfc) Collection (Entity type)	Metadatata for revefenacin
	DCSTRUCT ID 05303 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05303; PubChem_CID:11753673, FILE=drugcentral_drug_05303.json)
	revefenacin bioactivity Muscarinic acetylcholine receptor M2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	revefenacin bioactivity Muscarinic acetylcholine receptor M4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	revefenacin bioactivity Muscarinic acetylcholine receptor M1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	revefenacin bioactivity Muscarinic acetylcholine receptor M5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	revefenacin indication Chronic Obstructive Airway Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	revefenacin bioactivity Muscarinic acetylcholine receptor M3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG